US pharma industry sees a drop of 22.2% in deal activity in July 2019
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the…
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the…
Total pharma industry deals for July 2019 worth $4.57bn were announced globally, according to GlobalData's deals database. Embed this chart…
China's pharma industry saw a drop of 28.1% in overall deal activity during Q2 2019, when compared with the last…
North America's pharma industry saw a drop of 10.3% in overall deal activity during Q2 2019, when compared to the…
Europe's pharma industry saw a rise of 1.2% in overall deal activity during Q2 2019, when compared to the four-quarter…
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData's deals database. Embed this…
Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData's deals…
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData's deals database. Embed this chart…
Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData's deals database. Embed…
Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData's deals database. Embed…